valsartan/levamlodipine (SYH-9056)
/ CSPC Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
January 13, 2025
A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive Patients
(clinicaltrials.gov)
- P3 | N=606 | Not yet recruiting | Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Monotherapy • New P3 trial • Cardiovascular • Hypertension
1 to 1
Of
1
Go to page
1